Kallikrein 11 Antikörper (AA 68-82)

Produktnummer ABIN1736153

Produktdetails anti-Kallikrein 11 Antikörper

Target: Kallikrein 11 (KLK11)

Bindungsspezifität: AA 68-82

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Kallikrein 11 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: Reacts with human Hippostasin/KLK11

Aufreinigung: Antigen affinity purified

Immunogen: Residues 68-82 [YIVHLGQHNLQKEEG] of the 35 kDa human hippostasin/KLK11protein. Sequence identity to mouse and rat: 86%.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
- WB : 1/500 to 1/1 000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS, Sodium azide 0.02 %

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.

Haltbarkeit: 6 months

Details zu Kallikrein 11

Target: Kallikrein 11 (KLK11)

Andere Bezeichnung: Kallikrein-11 (KLK11 Produkte)

Synonyme: KLK11 antikoerper, 2310015I08Rik antikoerper, Prss20 antikoerper, TLSP antikoerper, PRSS20 antikoerper, kallikrein related peptidase 11 antikoerper, kallikrein related-peptidase 11 antikoerper, kallikrein-related peptidase 11 antikoerper, KLK11 antikoerper, Klk11 antikoerper

Hintergrund: Hippostasin, also known as KLK11, is a kallikrein-like serine protease, which has two alternatively spliced isoforms, brain-type and prostate-type.Hippostasin plays a role in the prostate, including reproductive and/or tumorigenic functions. Elevated serum levels of hK11 were found in 70 % of women with ovarian cancer and in 60 % of men with prostate cancer. Analysis of the KLK11 biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma.

Pathways: Komplementsystem